1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Distribution of pathologic subtypes in 390 included and 108 excluded patients
Null-Cell Mixed FSH GH PRL ACTH TSH LH Total Included Female 59 30 25 19 18 12 12 7 182 (47%) Male 83 38 16 21 15 21 9 5 208 (53%) Total 142 (36%) 68 (17%) 41 (11%) 40 (10%) 33 (8%) 33 (8%) 21 (5%) 12 (3%) Excluded Female 19 10 6 7 7 4 3 1 57 (53%) Male 20 9 8 5 4 3 1 1 51 (47%) Total 39 (36%) 19 (18%) 14 (13%) 12 (11%) 11 (10%) 7 (6%) 4 (4%) 2 (2%)